Effects of -Carotene and Other Factors on Outcome of Cervical Dysplasia and Human Papillomavirus Infection

By Romney S.L.   Ho G.Y.F.   Palan P.R.   Basu J.   Kadish A.S.   Klein S.   Mikhail M.   Hagan R.J.   Chang C.J.   Burk R.D.  

Gynecologic Oncology, Vol. 65, Iss. 3, 1997-06 ,pp. : 483-492

Elsevier

Access to resources Recommend Favorite

Evaluation of Antibodies to Human Papillomavirus as Prognostic Markers in Cervical Cancer Patients

By Silins I.   Avall-Lundqvist E.   Tadesse A.   Jansen K.U.   Stendahl U.   Lenner P.   Zumbach K.   Pawlita M.   Dillner J.   Frankendal B.  

Gynecologic Oncology, Vol. 85, Iss. 2, 2002-05 ,pp. : 333-338

Academic Press

Access to resources Recommend Favorite

Aberrant sialylation and fucosylation of intracellular proteins in cervical tissue are critical markers of cervical carcinogenesis

By Kim Hyoung Jin   Kim Seung Cheol   Ju Woong   Kim Yun Hwan   Yin Sun Young   Kim Hong-Jin  

Oncology Reports, Vol. 31, Iss. 3, 2014-03 ,pp. : 1417-1422

Spandidos Publications

Access to resources Recommend Favorite

Prediction of Recurrent and Residual Cervical Dysplasia by Human Papillomavirus Detection among Patients with Abnormal Cytology

By Bollen L.J.M.   Tjong-A-Hung S.P.   van der Velden J.   Mol B.-W.   ten Kate F.W.J.   ter Schegget J.   Bleker O.P.  

Gynecologic Oncology, Vol. 72, Iss. 2, 1999-02 ,pp. : 199-201

Elsevier

Access to resources Recommend Favorite

Changes in the topological expression of markers of differentiation and apoptosis in defined stages of human cervical dysplasia and carcinoma

By Zanotti S.   Fisseler-Eckhoff A.   Mannherz H.G.  

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 376-384

Elsevier

Access to resources Recommend Favorite